Sci Pharmtech (TPE:4119) Moat Score: 0/10 (As of Jul. 07, 2026)


TPE:4119 Sci Pharmtech Inc TPE:4119
67 GF Score
Price NT$44.75
GF Value NT$96.72
Valuation Possible Value Trap
! 9 Warning Signs
View Full Analysis

What is Sci Pharmtech Moat Score?

Sci Pharmtech has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Sci Pharmtech has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Sci Pharmtech might have No Moat - No discernible moat.

Sci Pharmtech  (TPE:4119) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Sci Pharmtech Moat Score Related Terms

TPE:4119
67GF Score
Sci Pharmtech Inc TPE:4119
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sci Pharmtech (TPE:4119) Overvalued in 2026?

Based on GuruFocus' analysis, Sci Pharmtech stock appears to be undervalued. The current stock price of NT$44.75 is trading 53.7% below its estimated GF Value™ of NT$96.72. GuruFocus considers Sci Pharmtech to be Possible Value Trap.

Key valuation signals for TPE:4119:

  • Moat Score: 0
  • GF Value™: NT$96.72 vs. price of NT$44.75 (53.7% below fair value)
  • GF Score™: 67/100 with 9 warning signs

No single metric tells the full story. See the TPE:4119 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sci Pharmtech Business Description

Address No.61, Lane 309, Haihu North Road, Luzhu District, Taoyuan, TWN, 33856
Sci Pharmtech Inc is engaged in the research and development, manufacture, and sales of active pharmaceutical ingredients, intermediates, and specialty chemicals. Geographically, the primary markets of the company are Italy, Germany, Japan, Taiwan, the United States, Switzerland, Spain, Belgium, Netherlands, and others.
67GF Score

Get the complete analysis for TPE:4119

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$44.75
Price
NT$96.72
GF Value